Buchumschlag

Niclosamide prodrug enhances oral bioavailability and efficacy against hepatocellular carcinoma by targeting vasorin‐TGFβ signalling

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Mingdian Tan, Wei Ye, Yi Liu, Xiaowu Chen, Lakshmi Huttad, Mei‐Sze Chua, Samuel So
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2025
Schlagworte:	British Journal of Pharmacology
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Enzyme‐responsive 612‐AYR nanoparticles for targeted inhibition of B4GALT3‐mediated ITGB1 glycosylation in hepatocellular carcinoma
von: Xiaohui Yu, et al.
Veröffentlicht: (2026)

Diltiazem N‐oxide, a novel ischaemia‐activated prodrug, prevents ischaemia‐induced ventricular fibrillation without off‐target adverse effects
von: Louise M. Hesketh, et al.
Veröffentlicht: (2026)

Beyond TGFβ inhibition: Chitosan oligosaccharide targets PGC‐1α‐mediated mitochondrial repair to combat pulmonary fibrosis
von: Huan He, et al.
Veröffentlicht: (2025)

Population pharmacokinetics and bioavailability of tacrolimus oral suspension in children with haematopoietic stem cell transplant
von: Lucas Brstilo, et al.
Veröffentlicht: (2025)

Pentagalloylglucose, a limited oral bioavailability polyphenol, improves allergic asthma through regulating gut microbiota and modulating enteritis
von: Xia'nan Sang, et al.
Veröffentlicht: (2026)

Clinical‐data‐driven pharmacological framework in liver disease: From liver cirrhosis to hepatocellular carcinoma
von: Ki‐Kwang Oh, et al.
Veröffentlicht: (2025)

Synergistic RU486 and olaparib therapy enhances apoptosis in endometriosis by simultaneously targeting hormonal signalling and DNA repair
von: Yujie Peng, et al.
Veröffentlicht: (2026)

Cost‐effectiveness of first‐line systemic therapies for unresectable hepatocellular carcinoma
von: Dai Lian, et al.
Veröffentlicht: (2024)

Ginsenoside Rf protects against acetaminophen‐induced liver injury by targeting CCAR2 to activate the SIRT1‐FXR signalling pathway
von: Jingjing Fan, et al.
Veröffentlicht: (2026)

Ligustilide alleviates hepatic fibrosis by targeting the mesenchymal homeobox 1 (MEOX1)– transcriptional enhanced associate domain factor 2 (TEAD2) signalling axis
von: Qinrong Luan, et al.
Veröffentlicht: (2026)

Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent
von: Bing Shang, et al.
Veröffentlicht: (2024)

Naringenin relieves paclitaxel‐induced pain by suppressing calcitonin gene‐related peptide signalling and enhances the anti‐tumour action of paclitaxel
von: Chen Pan, et al.
Veröffentlicht: (2024)

Recent advances in neuroinflammation prevention and therapy: the role of natural products and underlying mechanisms based on molecular targets
von: Mei‐Mei Zhao, et al.
Veröffentlicht: (2024)

Non‐canonical nitric oxide signalling and DNA methylation: Inflammation induced epigenetic alterations and potential drug targets
von: Christopher H. Switzer
Veröffentlicht: (2024)

C‐model: A comprehensive enhanced pharmacokinetic/pharmacodynamic simulation environment targeting the complement system
von: Lucía Alfonso‐González, et al.
Veröffentlicht: (2025)

Matsupexole: A novel nonergot dopamine receptor agonist with sustained efficacy in a rat model of Parkinson's disease and limited off‐target activity
von: Takayuki Suzuki, et al.
Veröffentlicht: (2026)

TNMplot: An enhanced platform for pharmacological target identification through cross‐stage and pan‐cancer gene expression analysis
von: Áron Bartha, et al.
Veröffentlicht: (2026)

Commentary on: Activation of Nrf2 signalling pathway by tectoridin protects against ferroptosis in particulate matter‐induced lung injury
von: Wenfu Cao, et al.
Veröffentlicht: (2024)

Reprogramming tumour‐associated macrophages in breast cancer via si‐FOXM1‐loaded lipid nanoparticles enhances immune checkpoint inhibitor efficacy
von: Yali Gao, et al.
Veröffentlicht: (2026)

Oral paltusotine, a nonpeptide selective somatostatin receptor 2 agonist: Mass balance, absolute bioavailability and metabolism in healthy participants
von: Rosa Luo, et al.
Veröffentlicht: (2025)

Cancer pain: current practice and emerging targets
von: Yi Ye, et al.
Veröffentlicht: (2026)

Recent innovations in targeting redox biology for therapeutics
von: Miriam M. Cortese‐Krott, et al.
Veröffentlicht: (2025)

Enterolactone promotes efficacy of gemcitabine on epithelial ovarian cancer and ameliorates gut dysbacteriosis
von: Danli Cao, et al.
Veröffentlicht: (2025)

Monocytic microRNAs—Novel targets in atherosclerosis therapy
von: Gerhild Euler, et al.
Veröffentlicht: (2024)

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy
von: Zihan Qu, et al.
Veröffentlicht: (2024)

Potential of natural flavonoids to target breast cancer angiogenesis (review)
von: Yuetong Wang, et al.
Veröffentlicht: (2024)

Galangin alleviates vitiligo by targeting ANXA2 degradation in macrophages
von: Wenjing Wei, et al.
Veröffentlicht: (2025)

Novel therapeutic targets for chronic visceral pain in gastrointestinal disorders
von: Fleur Veldman, et al.
Veröffentlicht: (2026)

Artificial intelligence streamlines scientific discovery of drug–target interactions
von: Yuxin Yang, et al.
Veröffentlicht: (2025)

Advancing Alzheimer's disease pharmacotherapy: efficacy of glucocorticoid modulation with dazucorilant (CORT113176) in preclinical mouse models
von: Geoffrey Canet, et al.
Veröffentlicht: (2025)

Compartmentalisation in cAMP signalling: A phase separation perspective
von: Milda Folkmanaite, et al.
Veröffentlicht: (2025)

Targeting the NLRP3 inflammasome signalling for the management of atrial fibrillation
von: Alisha Niskala, et al.
Veröffentlicht: (2024)

Improving K v 7 targeting anticonvulsants ‐ will repurposing save the day?
von: Nikita Gamper
Veröffentlicht: (2025)

Bioactive ligands targeting ectopic olfactory receptors: Implications for therapeutic strategies
von: Hui Zhao, et al.
Veröffentlicht: (2025)

Breaking the barriers: Overcoming cancer resistance by targeting the NLRP3 inflammasome
von: Nazanin Pazhouhesh Far, et al.
Veröffentlicht: (2024)

The use of different types of networks, alone and in combination, for drug target identification
von: Paolo Parini
Veröffentlicht: (2025)

Host genetic variants in the lactose metabolism pathway associated with bifidobacterium abundance have prognostic value for immunotherapy efficacy
von: Wen‐Hui Liu, et al.
Veröffentlicht: (2026)

The potential for biased signalling in the P2Y receptor family of GPCRs
von: Claudia M. Sisk, et al.
Veröffentlicht: (2025)

A computer‐aided drug repurposing: the antibacterial agents targeting GroEL
von: Dongdong Zhang, et al.
Veröffentlicht: (2025)

Dual pharmacological targeting of coactivator‐associated arginine methyltransferase 1 (CARM1) and salt inducible kinase (SIK) drives ketogenesis in both hepatocytes and mice
von: Tábata Bergonci, et al.
Veröffentlicht: (2026)